GSK Exclusive Interview Released

Lyophilization USA interviews Drug Product Development Specialist from GSK Vaccines

I enjoyed the conference and would love to come again…better opportunity for networking”

— Baxton

ISELIN, NEW JERSEY, UNITED STATES, July 24, 2017 /EINPresswire.com/ — SMi Group’s next annual Lyophilization USA show is thrilled to welcome Dr. Kelly Forney Stevens, Drug Product Development from GSK Vaccines onto speaker panel for 2017.

Kelly currently works in the Drug Product Development group and is responsible for the development of both the formulation and processing of vaccine drug products. Her research expertise is in lyophilization and solid-state formulations.

A key topic focus in Kelly’s presentation is understanding how and when phase separation occurs. Lyophilization of pharmaceutical proteins is often the only processing method that provides requisite long-term product stability. Freezing and drying, however, can cause acute damage to proteins. While great efforts are placed on developing a formulation and suitable lyophilization cycle, incompatibilities among components through freezing and drying have been almost completely ignored.

Hear more from Kelly at Lyophilization USA when she presents: ‘Assessing Phase Separation in Lyophilized Protein Formulations.’ For full presentation details, view the agenda here: www.lyophilization-usa.com/pr3

For those looking to attend there is currently a $100 early-bird saving.

Further information is available at: www.lyophilization-usa.com/pr3

SMi Presents the 3rd Annual Conference on…
Lyophilization USA
Date: November 16th – 17th 2017
Location: Iselin, New Jersey
Website: www.lyophilization-usa.com/pr3

Sponsored by: SCHOTT | TEMPRIS | W.L. GORE & ASSOCIATES, INC

—end—

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Pav Solanki
2078276048
email us here
SMi Group


Source: EIN Presswire

Multi Yogurt Machine Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022

Wiseguyreports.Com Adds “Multi Yogurt Machine Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database

PUNE, INDIA, July 24, 2017 /EINPresswire.com/ — Global Multi Yogurt Machine Industry

Latest Report on Multi Yogurt Machine Market Global Analysis & 2022 Forecast Research Study

Global Multi Yogurt Machine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
Cuisinart 
Euro-Cuisine 
Oster 
Aroma 
Joyoung 
Hamilton Beach 
Yonanas 
Spaceman 
Panasonic 
Yogourmet 
Dash 
Salton 
Epica 
Deni 
Vonshef 
Taizhou PASMO FOOD TECHNOLOGY 

Try Sample Report @ https://www.wiseguyreports.com/sample-request/1617016-global-multi-yogurt-machine-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Multi Yogurt Machine in these regions, from 2012 to 2022 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Full-automatic type 
Semi-automatic type 
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Multi Yogurt Machine for each application, including 
Household 
Commercial

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/1617016-global-multi-yogurt-machine-market-research-report-2017

Some Major Points from Table of content:

Global Multi Yogurt Machine Market Research Report 2017 
1 Multi Yogurt Machine Market Overview 
1.1 Product Overview and Scope of Multi Yogurt Machine 
1.2 Multi Yogurt Machine Segment by Type (Product Category) 
1.2.1 Global Multi Yogurt Machine Production and CAGR (%) Comparison by Type (Product Category)(2012-2022) 
1.2.2 Global Multi Yogurt Machine Production Market Share by Type (Product Category) in 2016 
1.2.3 Full-automatic type 
1.2.4 Semi-automatic type 
1.3 Global Multi Yogurt Machine Segment by Application 
1.3.1 Multi Yogurt Machine Consumption (Sales) Comparison by Application (2012-2022) 
1.3.2 Household 
1.3.3 Commercial 
1.4 Global Multi Yogurt Machine Market by Region (2012-2022) 
1.4.1 Global Multi Yogurt Machine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 
1.4.2 North America Status and Prospect (2012-2022) 
1.4.3 Europe Status and Prospect (2012-2022) 
1.4.4 China Status and Prospect (2012-2022) 
1.4.5 Japan Status and Prospect (2012-2022) 
1.4.6 Southeast Asia Status and Prospect (2012-2022) 
1.4.7 India Status and Prospect (2012-2022) 
1.5 Global Market Size (Value) of Multi Yogurt Machine (2012-2022) 
1.5.1 Global Multi Yogurt Machine Revenue Status and Outlook (2012-2022) 
1.5.2 Global Multi Yogurt Machine Capacity, Production Status and Outlook (2012-2022)

2 Global Multi Yogurt Machine Market Competition by Manufacturers 
2.1 Global Multi Yogurt Machine Capacity, Production and Share by Manufacturers (2012-2017) 
2.1.1 Global Multi Yogurt Machine Capacity and Share by Manufacturers (2012-2017) 
2.1.2 Global Multi Yogurt Machine Production and Share by Manufacturers (2012-2017) 
2.2 Global Multi Yogurt Machine Revenue and Share by Manufacturers (2012-2017) 
2.3 Global Multi Yogurt Machine Average Price by Manufacturers (2012-2017) 
2.4 Manufacturers Multi Yogurt Machine Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Multi Yogurt Machine Market Competitive Situation and Trends 
2.5.1 Multi Yogurt Machine Market Concentration Rate 
2.5.2 Multi Yogurt Machine Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

For Detailed Reading Please visit WiseGuy Reports @     https://www.wiseguyreports.com/reports/1617016-global-multi-yogurt-machine-market-research-report-2017

3 Global Multi Yogurt Machine Capacity, Production, Revenue (Value) by Region (2012-2017) 
3.1 Global Multi Yogurt Machine Capacity and Market Share by Region (2012-2017) 
3.2 Global Multi Yogurt Machine Production and Market Share by Region (2012-2017) 
3.3 Global Multi Yogurt Machine Revenue (Value) and Market Share by Region (2012-2017) 
3.4 Global Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.5 North America Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.6 Europe Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.7 China Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.8 Japan Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.9 Southeast Asia Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
3.10 India Multi Yogurt Machine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Multi Yogurt Machine Supply (Production), Consumption, Export, Import by Region (2012-2017) 
4.1 Global Multi Yogurt Machine Consumption by Region (2012-2017) 
4.2 North America Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017) 
4.3 Europe Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017) 
4.4 China Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017) 
4.5 Japan Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017) 
4.6 Southeast Asia Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017) 
4.7 India Multi Yogurt Machine Production, Consumption, Export, Import (2012-2017)

Continued…..

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Tendinitis Treatment Market Forecast 2022: Growth Factors, Trends, Top Companies Analysis for Business Prospects

Tendinitis Treatment Market – Global Forecast till 2023

Tendinitis treatment market by condition (tennis elbow, golfer's elbow), by diagnosis (physical exam), by treatment, by end user- global forecast till 2023

Major key Players include Almatica Pharma, Inc,AstraZeneca,Bayer,Boehringer Ingelheim Pharmaceuticals, Inc.,Merck & Co.,Pfizer”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, July 24, 2017 /EINPresswire.com/ — Market Highlights
The global tendinitis treatment market has been evaluated as a steadily growing market and it is expected to continue growing in the near future.
The cases of tendinitis are increasing. Sport injuries is one of the major driver for this market. Increasing adoption of new treatment and therapies, growing awareness, and increasing healthcare expenditure are driving the market growth. Top players of this market are investing for research and new product development as well as they are collaborating with medical research centers and academic institutions to derive effective solution for tendinitis.
The market for tendinitis treatment was around USD 328.4 million in 2016 and is expected to reach USD 426.4 million by 2023 which is a projected CAGR of 3.8% during 2017-2023.

Key players for global Tendinitis treatment market:
• Almatica Pharma, Inc. (US),
• AstraZeneca (US),
• Bayer (Germany),
• Boehringer Ingelheim Pharmaceuticals, Inc. (US),
• Merck & Co.Inc (US),
• Pfizer (US),
• others.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Tendinitis Treatment Market – Global Forecast till 2023

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/3876

Regional Analysis:
Considering the global scenario of the tendinitis treatment market, there are four main regions, the Americas, Europe, Asia Pacific, and Middle East and Africa.
The Americas is dominating region in global tendinitis treatment market. North America is highest revenue generator and important contributor in this market. Advance treatment facilities and fast adoption of new therapies are driving growth for this market. Europe is the second largest market for tendinitis treatment. Increasing cases of sport injuries and availability of products as well as treatment options are driving the growth for European tendinitis market. The western European countries like Germany, France and UK are holding the largest market share while Eastern European region is also growing at steady pace. The rapid growth of healthcare sector and increasing spending on health related problems are some of the driving factors for the growth of Asia Pacific tendinitis treatment market. Middle East and Africa market is growing slower than the global average. Middle Eastern region is growing significantly as compared to Africa it is mainly due to developed healthcare infrastructure, government support, and extended insurance cover.

Access Report Details @ https://www.marketresearchfuture.com/reports/tendinitis-treatment-market-3876

Segments:
Global tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's knee, and others.
On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.
On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Table of Content

1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger And Acquisition Landscape
5.7 Upcoming Trends
5.7.1 Market Trends
5.7.2 Technological Trends
5.7.3 Insurance & Regulations
5.7.4 Others
6. Global Tendinitis Treatment Market By Problem
Continue………..

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Population Health Management Market Share, Opportunities, competitor Strategy and Forecast to 2023.

Global Population Health Management Market Information; by Component,by Application; by Delivery mode and by End user – Forecast to 2023

Major key Players include Allscripts, Inc.;Cerner Corporation;Conifer Health Solutions, McKesson Corporation,Wellcentive, Inc.,Epic Corporation, Inc”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, July 24, 2017 /EINPresswire.com/ — Market Highlights
Global Population Health Management Market is expected to grow at 21.2% CAGR during 2017-2023 this growth due to shift to outcome based healthcare system
The global population health management market has been evaluated as a high growth market with the potential for explosive growth. As the population health management system is a latest development it is suffering from inconsistent development. Thus no single player in the market has complete and comprehensive solutions. Thus any first comer with a novel and comprehensive solution will grow at an explosive growth with minimum marketing cost and faster market uptake.
Another development is the collaboration between data companies and large healthcare players. This benefits both partners as data companies get access to data of the healthcare players and the large healthcare player can save on costs.

Key players of Global Population Health Management Market:
• Allscripts, Inc.;
• Cerner Corporation;
• Conifer Health Solutions, LLC,
• McKesson Corporation,
• Wellcentive, Inc.,
• Epic Corporation, Inc.,
• IBM Corporation etc.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/3123

The global population health management market is a consolidated market with a hand full of large players. Product development is the best strategy to be a market leader in such a situation. Large market players include IBM Corporation and SAS.

The market favors a player offering a comprehensive and complete integrated solution. Thus players with established expertise in data warehousing and analytics will have an edge over others. Thus IBM Corporation, with its huge data warehouse setups and expertise in analytics is a strong player. SAS also has a strong presence in population health management.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 200 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Population Health Management Market Research Report- Global Forecast To 2023”

Segmentation:
The global population health management market is segmented
Segmentation based on component. the market has been segmented as software and service.
Segmentation based on applications, the market has been segmented into healthcare economics and resource management, healthcare coordination & consultancy, clinical and compliance studies and surveillance and others.
Segmentation based on the delivery mode, the market has been segmented into on-premise, web and cloud based & mobile based and
Segmentation based on end user, the market has been segmented into healthcare providers, healthcare payers, government organizations and others.

Browse full report @ https://www.marketresearchfuture.com/reports/population-health-management-market-3123

Table of Content

1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Population Health Management Market, By Component
Continue………

Key questions answered in this report
• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Related Reports
Global Cardiac Catheterization Market Information by Types (Angiographic Balloon Catheter, Arterial Embolectomy, Bipolar Pacing) by Applications (Coronary angiogram, Right heart catheterization, Heart biopsy) – Forecast to 2027. Know more about this report @ https://www.marketresearchfuture.com/reports/cardiac-catheterization-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Spinal Traction Market share, Trend, Competitor Strategy and Forecast to 2022.

Spinal Traction Market by Types (manual spinal traction, mechanical spinal traction) by applications (slipped discs, bone spurs) by devices – Forecast to 2022

Major key Players include DJO Global,STOLL Medizintechnik GmbH,RS Medical,Hill Laboratories Company,Mettler Electronics Corp,Antalgic-Trak”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, July 24, 2017 /EINPresswire.com/ — Market Synopsis of the Market:
Market Scenario:
Spinal traction is a procedure of decompression therapy that releases pressure on the spine. It can be executed manually or mechanically. Globally the market for spinal traction is expected to grow at the rate of about XX% from 2016 to 2022.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Spinal Traction Market Research Report- Global Forecast To 2022

Key Players for the Market:
• DJO Global,
• STOLL Medizintechnik GmbH,
• RS Medical,
• Hill Laboratories Company,
• Mettler Electronics Corp,
• Antalgic-Trak,
• Medtronic
• others.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1902

Segments:
Spinal Traction market has been segmented
On the basis of types which comprises of Manual spinal traction, Mechanical spinal traction.
On the basis of applications the market is segmented into slipped discs, bone spurs, degenerative disc disease, herniated discs, facet disease, sciatica, foramina stenosis, pinched nerves and others.
On the basis of devices the market is segmented into continuous traction, gravity-dependent traction, manual traction, others.

Key Finding
• The European market is expected to reach $XX billion by 2022.
• Anticonvulsant medication holds the largest share of XX% of the Spinal Traction market.
• North America holds the largest market share of XX% of Spinal Traction and is expected to reach $XX billion by the end of forecast period.
• Asia Pacific is expected to be the fastest growing market at a CAGR of XX%

Browse full report @ https://www.marketresearchfuture.com/reports/spinal-traction-market

Table of Content

1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Spinal Traction Market, by Types
5.1 Introduction
5.1.1 Manual spinal traction
5.1.2 Mechanical spinal traction
5.1.3 Others
6 Global Spinal Traction Market, by Applications
Continue………..

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Blood Plasma 2017 Global Market Outlook,Research,Trends and Forecast to 2021

WiseGuyReports.Com Publish a New Market Research Report On – “Blood Plasma 2017 Global Market Outlook,Research,Trends and Forecast to 2021”.

PUNE, INDIA, July 22, 2017 /EINPresswire.com/ —

This report studies the Blood Plasma market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Blood Plasma market by product type and applications/end industries.
The global Blood Plasma market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/1618081-2017-2022-blood-plasma-report-on-global-and-united-states-market

For more information or any query mail at sales@wiseguyreports.com

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Plasma. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Blood Plasma in these regions, from 2012 to 2022 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States Blood Plasma market, including Grifols S.A (Spain), Octopharma AG (Octapharma), Biotest AG (USA), Baxter (USA), Shire (Dublin), CSL Ltd (Australia), Kedrion S.p.A. (Italia), Sanquin (Amsterdam), Hualan Biological Engineering Inc (China), Shanghai Raas Blood Products Co. Ltd (China), LB Diagnostic Laboratory (USA), Access Clinical (USA

The On the basis of product, the Blood Plasma market is primarily split into
Albumin Products
Immune Globulin Products
Blood Coagulation Factor Products
On the basis on the end users/applications, this report covers
Hemophilia A
Hemophilia B
Von Willebrand Disease
Other Factor Deficiencies

Report Details @ https://www.wiseguyreports.com/reports/1618081-2017-2022-blood-plasma-report-on-global-and-united-states-market

Table Of Contents – Major Key Points

1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
2.1.1 Secondary Sources
2.1.2 Primary Sources
1.3 Disclaimer

……..

7 Blood Plasma Players/Manufacturers Profiles and Sales Data
7.1 Grifols S.A (Spain)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Blood Plasma Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Grifols S.A (Spain) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Octopharma AG (Octapharma)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Blood Plasma Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Octopharma AG (Octapharma) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Biotest AG (USA)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Blood Plasma Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Biotest AG (USA) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Baxter (USA)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Blood Plasma Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Baxter (USA) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Shire (Dublin)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Blood Plasma Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Shire (Dublin) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.5.4 Main Business/Business Overview
7.6 CSL Ltd (Australia)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Blood Plasma Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 CSL Ltd (Australia) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Kedrion S.p.A. (Italia)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Blood Plasma Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Kedrion S.p.A. (Italia) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Sanquin (Amsterdam)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Blood Plasma Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Sanquin (Amsterdam) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Hualan Biological Engineering Inc (China)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Blood Plasma Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Hualan Biological Engineering Inc (China) Blood Plasma Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.9.4 Main Business/Business Overview

Continue…….

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1618081

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Life Science Instruments & Reagents Market 2017 – Forecast to 2023

Life Science Instruments & Reagents Market

WiseGuyReports.com adds “Life Science Instruments & Reagents Market 2017 Global Analysis Research Report Forecasting to 2023”reports to its database.

PUNE, INDIA, July 21, 2017 /EINPresswire.com/ — Life Science Instruments & Reagents Market:

Executive Summary

This report studies the life science instruments and reagents market over the forecast period of 2017 to 2023. The life science instruments and reagents market is expected to grow at a high single digit CAGR to reach $81,325 million by 2023. The report covers all life instruments and associated reagents used in pharmaceuticals, biotechnology and diagnostics that help cutting edge research and innovative application. These technologies include from basic to advanced technologies including spectrometry, chromatography, microscopy, PCR, flow cytometry, laboratoy centrifuges, electrophoresis, NGS, biochips, automated liquid handling and robotics, cell counters, laboratory freezers and others. This report does not include medical devices or in-vitro diagnostics market; however the usage of instruments and reagents for diagnostic purpose is included in the market. The life science instruments and reagents global market is segmented based on technology, applications, products, end users and geography.

The life science instruments and reagents global market is a fragmented market with key players such as Agilent Technologies (U.S.), BD and Company (U.S.), Bio-Rad Laboratories (U.S.) Bruker Corporation (U.S.), Danaher Corporation (U.S.), Illumina, Inc. (U.S.), Merck KGaA (Germany), Perkinelemer, Inc. (U.S.), Roche Holdings (Switzerland), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.) and Waters Corporation (U.S.).

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1000925-life-science-instruments-reagents-global-market-forecast-to-2023

Spectrometry global market is segmented based on technology and application. Based on technology type, spectrometry market is segmented into atomic spectrometry, mass spectrometry, molecular spectrometry. The spectrometry market by application is segmented into biotechnology and pharmaceutical. Chromatography global market is segmented based on technology type, products and application. Based on technology type, chromatography market is divided into liquid chromatography, gas chromatography, super critical fluid chromatography and thin layer chromatography. Chromatography global market by products is further segmented into instruments, columns and reagents & consumables. Chromatography market based on application is divided into drug discovery and development, manufacturing, Omics and clinical diagnostics. Microscopy global market is segmented into technology type and application. Based on technology type, microscopy is segmented into electron microscopy, optical microscopy, confocal microscopy and scanning probe microscopy. Based on application, microscopy market is classified into cell biology, clinical/pathology, pharmacology & toxicology and clinical diagnostics.

PCR global market is segmented based on technology type, products and application. Based on technology type, PCR market is segmented into standard PCR, real-time PCR/Q PCR, Reverse Transcriptase PCR, digital PCR, assembly PCR and others. PCR market based on products is segmented into instruments, reagents & consumables, software & services. Based on application, PCR market is segmented into clinical diagnostics, industrial and others. Flow cytometry global market is segmented into technology type, products and application. Based on technology type, flow cytometry market is divided into cell based assay and bead based assay. Flow cytometry market based on products is classified into Instruments and reagents and consumables. Based on application, flow cytometry market is segmented into research, clinical diagnostics and pharmaceutical and biotechnology. Centrifugation global market is segmented based on technology type and application. Based on technology type, centrifugation market is segmented into micro-centrifugation, high-speed/super speed centrifugation, ultra-centrifugation. Centrifugation market based on application is segmented into research, diagnostics and manufacturing.

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/1000925-life-science-instruments-reagents-global-market-forecast-to-2023

Electrophoresis global market is segmented based on technology type, products and application. Based on technology type, electrophoresis market is segmented into gel electrophoresis and capillary electrophoresis. Electrophoresis market based on products is classified into instruments and reagents & consumables. Based on application, electrophoresis market is segmented into research, diagnostics and pharmaceutical & biotechnology. NGS global market is segmented based on technology type, products and application. Based on technology type NGS market is segmented into reversible terminator sequencing, Ion Semi-conductor sequencing, sequencing by ligation, Single molecule real time sequencing and others. NGS market based on products is divided into instruments, services and NGS workflow products. Based on application, NGS market is segmented into by process and by field. NGS application by process is segmented into genomics, epigenomics, transcriptomics and others. NGS application by field is segmented into diagnostics, drug discovery and development and biomarker discovery. Biochips global market is segmented based on technology type, products and application. Based on technology type biochips market is segmented into microarray and microfluidics/lab-on-a-chip. Biochips market based on products is divided into instruments, reagents & consumables, software, services. Based on application, biochips market is segmented into diagnostics, drug discovery & development and research.

Automated liquid handling & robotics global market is segmented based on application into diagnostics, drug discovery & development and research. Others segment includes sterilization, western blotting, colorimeters, incubator and fume hoods. Depending on the end users, the life science instruments and reagents global market is sectioned into academic & government institutions, pharmaceutical & biotechnology companies, hospitals and diagnostic centers and others.

Increased focus on R&D expenditure and growth of biotechnology and pharmaceutical industries, technological advancements in analytical devices, growth in funding for research, rising demand of analytical instruments with growing research activities in proteomics, lucrative growth opportunities in emerging markets and increasing demand from various industries. Factors such as high cost of instruments, dearth of skilled professionals and stringent regulations are hampering the market growth.
Geographically, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America dominated the life science instruments and reagents market with the largest share which is driven by factors such as increasing awareness of technology, proximity of companies, and early adoption of latest treatments. The European market is expected to be second largest market, growing at a lower rate mainly due to the stringent regulatory environment and slow growth due to the economic crisis. The Asian market is expected to occupy third place with highest growth due increasing government funding of research, economic prosperity, early adoption of latest technology and the relaxed regulatory environment.

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1000925

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Contraceptive Drugs Market is Expected to Reach Till $ 22.15 Billion By 2023

Contraceptive Drugs Market

Contraceptive Drugs Market

Market Research Future published a half-cooked research report on global contraceptive drugs market. Its expected to reach at a CAGR of 6.5% by 2023

PUNE, MAHARASHTRA, INDIA, July 21, 2017 /EINPresswire.com/ — Global Contraceptive Drugs Market Research Report, By Type (Oral Contraceptives, Injectable And Others), By End Users (Hospitals, Clinics And Others) – Forecast Till 2023
Contraceptive drugs has got a special attention from 20th century. These are the products that helps to avoid unwanted birth. These products help in preventing the pregnancy by blocking or altering the process of ovulation. The major driving factor for the growth of global contraceptive drugs market is increasing need to control the population. Beside this economic advances, increasing awareness different government initiatives are also responsible for the growth of the global contraceptive drugs market. On other hand side effects of the contraceptives, many religious and cultural opposition may restrain the growth of the market. The global market for contraceptive drugs is expected to reach $ 22.15 billion by the end of the 2023 form $ 13.9 billion in 2016, at a CAGR of 6.5%.

Get a sample report at https://www.marketresearchfuture.com/sample_request/1276 .

Segmentation:
Global contraceptive drugs market is segmented on two category by type and by end user. On the basis of type they are oral contraceptive, injectable and other. Oral contraceptives are further sub segmented into combined oral contraceptive pills and progestogen- only pills. On the basis of end user they are segmented as hospitals, clinics and others.
The major key player for the global contraceptive drugs market are
• Merck & Co., Inc (US)
• Pfizer Inc (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Bayer AG (Germany)
• Allergan plc. (Ireland)
• Janssen Global Services llc. (US)
• Mankind Pharma Ltd. (India)
• Piramal Enterprises Ltd (India)
• Reckitt Benckiser Plc (UK)
• Church & Dwight (US)
• The Female Health Company (US)
• Mayer Laboratories (US)
• Cooper Surgical (US)

Global contraceptive market is contributed by many of the small and large companies. Major companies are investing in R&D so as to introduce more innovative and efficient contraceptives drugs as they are under constant pressure to launch new and technologically advanced products. Companies are launcing new product so as to withstand the competition and increase the market.
Pfizer Inc one of the leading research and pharmaceutical company headquartered in US. In 2015, they has introduced SAYANA, first injectable contraceptive in UK which can be self-administered. Loette, Premarin and Ovral are some of the major products of Pfizer.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Israel. In 2015, company has launched Beyaz which is a generic contraceptive drug. It is one of the most successful product of the company and in 2016 it has annual sales of approximately $133 million in the US. Recently, in March 2017 Company has announce to launch a new product Minastrin.
Merck & Co., Inc is one of the largest pharmaceutical companies in the world headquartered in US. Cyclessa, Desogen and Dificid are some of the major products of the company.
Bayer AG is a multinational chemical, pharmaceutical company headquartered in Germany. Company has developed a new class of birth control pill QLAIRA. This drug has shown a well-tolerated and high satisfaction rate in studies.
Allergan plc is the multinational company headquartered in Ireland. This company produces branded and generic drugs and performs pharmaceutical research and development. In 2016, company has announce to launch TAYTULLA, first and only oral contraceptive in a softgel capsule.

Browse complete report at https://www.marketresearchfuture.com/reports/contraceptive-drugs-market-1276 .

Study Objectives global contraceptive drugs market
• Detailed overview of global contraceptive drugs market.
• Detail analysis of global contraceptive drugs market with all possible segmentation and key player of market.
• Detailed analysis of the historical and forecasted market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global contraceptive drugs market.
• Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- America, Europe, Asia Pacific and Middle East and Africa.
• Insights on the major countries/regions in which this industry is flourishing and to also identify the untapped regions which could be the potential markets in future
Intended Audience
• Research and Development (R&D) Companies
• Contraceptive drugs manufacturers
• Medical Research Laboratories
• Academic Medical Institutes and Universities
• Government and Independent Research Laboratories
• Contract Research Organizations (CROs)

Get a discount at https://www.marketresearchfuture.com/check-discount/1276 .

The report for global contraceptive drugs market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Hello Bio launches ‘ready-made’ cesium gluconate for electrophysiologists

Hello Bio launches ‘ready-made’ cesium gluconate

Hello Bio announced today the launch of cesium gluconate – a novel tool for electrophysiologists wishing to make internal solutions for patch clamp experiments

We are delighted to be the first supplier of cesium gluconate. It’s ‘ready-made’ so can save electrophysiologists lots of time and effort as they don’t need to make it themselves. ”

— Steve Roome PhD, Managing Director and Founder, Hello Bio

BRISTOL, UK, July 21, 2017 /EINPresswire.com/ — Electrophysiologists routinely use a technique called ‘patch clamping’ to study the behavior of single or multiple ion channels and the electrical properties of cells. Patch clamp recording uses a glass micropipette called a patch pipette as a recording electrode – this can be filled with an ‘intracellular’ or internal solution.

Traditionally, to make a cesium gluconate based intracellular solution, researchers would have to prepare their own – and depending on the chosen method, this could involve mixing reagents, titrating, decolourising, and washing. However, with the availability of ready-made cesium gluconate, these methods are not required, and the cesium gluconate can be added to the solution in one easy step.

We are delighted to be the first supplier of cesium gluconate. It’s ‘ready-made’ so can save electrophysiologists lots of time and effort as they don’t need to make it themselves. Hello Bio’s ready-made cesium gluconate now makes it that much easier and quicker for electrophysiologists to prepare their own cesium-gluconate based internal (intracellular) solutions..

Steve Roome PhD, Managing Director and Founder, Hello Bio

Cesium gluconate joins a range of affordable and high quality tools for electrophysiologists including D-AP5, tetrodotoxin citrate, NBQX disodium salt, QX-314 and Kynurenic acid sodium salt.

CONTACT

For more information, please contact
Steve Roome:
hello@hellobio.com
(0)117 3180 505

FURTHER INFORMATION

Hello Bio was founded by a team of experienced scientists and chemists who genuinely want to support life science research. Our aim is to offer a range of high quality life science tools at prices so low that as many researchers as possible will be able to afford them.

We offer a range of agonists, antagonists, inhibitors, activators, antibodies and fluorescent tools at up to half the price of other suppliers. The range includes:

Enzyme inhibitors and activators
Epigenetic tools

Ion channel modulators
Receptor ligands & DREADDs

Signaling tools
Stem cell modulators and more…
We also offer a cost effective custom synthesis service for customers requiring specialist tools, or bulk quantities.

Steve Roome
Hello Bio
0117 318 0505
email us here


Source: EIN Presswire

Human Genetics Market Analysis, Opportunities, Key Applications and Forecast to 2024

Human genetic market, by instruments (Accessories, Device), by end-user (Hospital, Clinic, Research center), by method, by application – Global Forecast 2024

Major Key Players are Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, July 21, 2017 /EINPresswire.com/ — About Human Genetics Market:

Genetics is the study of genes, their functions and their effects. Among the various types of genetics such as molecular genetics, developmental genetics, population genetics and quantitative genetics, human genetics is the study that deals with the inheritance occurs in human beings. It encompasses a variety of overlapping fields such as classical genetics, cytogenetic, molecular genetics, genomics and many more.

The study of human heredity occupies a central position in genetics. Much of this interest stems from a basic desire to know who humans are and why they are as they are. It can be useful as it can answer questions about human nature, understand the diseases and development of effective disease treatment, and understand genetics of human life. At a more practical level, an understanding of human heredity is of critical importance in the prediction, diagnosis, and treatment of diseases that have a genetic component.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/714

Major Key Players:

• Agilent Technologies (U.S.),
• Bode Technology (U.S.),
• GE Healthcare (U.K.),
• Illumina (U.S.),
• LGC Forensics (U.K.),
• Orchid Cellmark, Inc. (U.S.),
• Promega Corporation (U.S.),
• QIAGEN N.V. (Netherlands),
• Thermo Fisher Scientific, Inc. (U.S.).
Human Genetics Market Growth Influencer:

The growth driver includes: advancement of genetics testing technologies, rising genetic diseases, and rising awareness in terms of increasing knowledge about the potential benefits in genetic testing. Furthermore, aging population and increasing incidence of cancer cases are the other factors propelling growth of human genetics market.

The market for screening the newborns, diagnosing rare and fatal disorders, and predicting the probability of occurrence of abnormalities & diseases are likely to expand. Particularly, genetic tests to screen the newborns are expected to expand immensely over the coming years. Furthermore, the genetic disorders caused by microorganisms such Zika virus is one of the major concern behind of microcephaly. Microcephaly is a birth defect that is associated with a small head and incomplete brain development in newborns that transferred from mother to her child. Such, diseases are expected raise the application of the human genetic studies there by driving by the market. However, the high costing instruments and lack of experienced professionals are the major restraints for the growth of Human genetics market.

Test the market data and market information presented through more than 50 market data tables and figures spread over 121 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Human Genetics Market Research Report – Global Forecast to 2024”.

Browse Report @ https://www.marketresearchfuture.com/reports/human-genetics-market

Human Genetics Market Segmentation:
The Human genetics market can be segmented into by methods, by product, by applications and by end-users.
Major Human genetics market by methods: cytogenetic, molecular, presymptomatic and prenatal.
Human genetics market by product: Consumables, devices and accessories
Human genetics market by applications: research, diagnostic and forensic science and others.
Human genetics market by end-users: hospitals, clinics, research centers and forensic departments.

Latest Trends:
Agilent technologies have developed Human Gene expression micro arrays in 2014which provide comprehensive coverage of genes and transcripts using the latest annotation databases. It provides up-to date content; widest dynamic range of over 5 logs ensures detection of low and high expressers for the most biologically relevant data and fully customizable content with multiple formats for the most flexible experimental design

Bode Technology (Bode), one of the leading providers of forensic DNA services, has acquired Chromosomal Laboratories, Inc. in 2012, a leading provider of DNA testing for immigration and private paternity. By adding this expertise to its portfolio of service offerings, Bode is utilizing its vast international and domestic presence to provide best in class immigration paternity and private paternity testing to clients worldwide. Bode is a wholly owned subsidiary of Solution Point International, Inc.

The report on Human Genetics Market comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/714

This report will provide the clear picture of current market scenario of Human genetic market globally as well as the country level markets. The report also provides the information about human genetic market by various methods which are used to perform the testing, by products and by applications. It also provides the detailed information about the study and research which are being performed by the forensic and diagnostic institutes and departments which will benefit the end users and global test device manufacturers and suppliers.

Browse Related Statistical Report
North America Insulin Pump Market is projected to grow at a CAGR of 8.8 % and is expected to reach US$ 3,196.2 million by 2023. In North America Insulin Pump Market, US accounted for the largest market share in 2016.

https://www.marketresearchfuture.com/statistical-reports/north-america-insulin-pump-market-3697

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire